Search
Showing results for "lung disease preterm"
A bold research program is working to give young children lifelong protection against influenza
COVID-19 related non-pharmaceutical interventions (NPIs) disrupted global healthcare utilisation, with notable declines in infection related paediatric hospitalisations. We aimed to identify non-infectious paediatric conditions for which the incidence of hospital admissions increased during the introduction and alleviation of NPIs in 2020.
Immunity is distinct in early life and greater precision is required in our understanding of mechanisms of early life protection to inform development of new pediatric vaccines
One in four ED presentations in WA children are for ARIs, representing a significant out-of-hospital burden with some evidence of geographical disparity
A vaccine that prevents GAS cellulitis and other skin infections, in addition to throat infections, would maximise its value and commercial viability
We will investigate the relationship between PCV coverage and VT carriage among undervaccinated children in Asia and the Pacific
Reliance on hospital discharge diagnosis codes alone will likely underestimate the burden of respiratory viruses
Early 7vPCV schedules have limited impact on pneumococcal vaccine type carriage in PNG
Pneumococcal surface protein A is immunogenic and natural anti-PspA immune responses are acquired through exposure and develop with age
The benefits that swimming pools may bring to to ear and eye health in remote Aboriginal communities remains unresolved